Fagron NV
XBRU:FAGR
Relative Value
The Relative Value of one
FAGR
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 22.1 EUR,
Fagron NV
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
FAGR Competitors Multiples
Fagron NV Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| BE |
|
Fagron NV
XBRU:FAGR
|
1.6B EUR | 1.8 | 18.9 | 11.9 | 13.7 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
104.7B USD | 0.3 | 26 | 18.3 | 20.6 | |
| US |
|
Cencora Inc
NYSE:COR
|
70.5B USD | 0.2 | 45.4 | 15.3 | 19.7 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
70.3B USD | 0.2 | 45.2 | 15.3 | 19.6 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
51.8B USD | 0.2 | 32.5 | 15.9 | 20.8 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
36.1B AUD | 6 | 68 | 51.2 | 51.2 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.4B CNY | 0.2 | 11.2 | 15.1 | 15.1 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63B CNY | 1.5 | 17 | 13.1 | 13.1 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD | 0.7 | 22.9 | 11.1 | 15.4 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.3B HKD | 0.1 | 8.5 | 1.5 | 2 |